289 related articles for article (PubMed ID: 20171418)
1. The economic implications of treating atherothrombotic disease in Australia, from the government perspective.
Ademi Z; Liew D; Hollingsworth B; Wolfe R; Steg GP; Bhatt DL; Reid CM;
Clin Ther; 2010 Jan; 32(1):119-32; discussion 106-7. PubMed ID: 20171418
[TBL] [Abstract][Full Text] [Related]
2. One-year costs in patients with a history of or at risk for atherothrombosis in the United States.
Mahoney EM; Wang K; Cohen DJ; Hirsch AT; Alberts MJ; Eagle K; Mosse F; Jackson JD; Steg PG; Bhatt DL;
Circ Cardiovasc Qual Outcomes; 2008 Sep; 1(1):38-45. PubMed ID: 20031786
[TBL] [Abstract][Full Text] [Related]
3. Predictors of annual pharmaceutical costs in Australia for community-based individuals with, or at risk of, cardiovascular disease: analysis of Australian data from the REACH registry.
Ademi Z; Liew D; Hollingsworth B; Steg PG; Bhatt DL; Reid CM;
Am J Cardiovasc Drugs; 2010; 10(2):85-94. PubMed ID: 20334445
[TBL] [Abstract][Full Text] [Related]
4. Drug treatment and cost of cardiovascular disease in Australia.
Ademi Z; Liew D; Chew D; Conner G; Shiel L; Nelson M; Soman A; Steg G; Bhatt DL; Reid C;
Cardiovasc Ther; 2009; 27(3):164-72. PubMed ID: 19689615
[TBL] [Abstract][Full Text] [Related]
5. Two-year vascular hospitalisation rates and associated costs in patients at risk of atherothrombosis in France and Germany: highest burden for peripheral arterial disease.
Smolderen KG; Wang K; de Pouvourville G; Brüggenjürgen B; Röther J; Zeymer U; Parhofer KG; Steg PG; Bhatt DL; Magnuson EA;
Eur J Vasc Endovasc Surg; 2012 Feb; 43(2):198-207. PubMed ID: 22001145
[TBL] [Abstract][Full Text] [Related]
6. Economic outcomes in patients diagnosed with systemic lupus erythematosus with versus without nephritis: results from an analysis of data from a US claims database.
Pelletier EM; Ogale S; Yu E; Brunetta P; Garg J
Clin Ther; 2009 Nov; 31(11):2653-64. PubMed ID: 20110008
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular event rates in diabetic and nondiabetic individuals with and without established atherothrombosis (from the REduction of Atherothrombosis for Continued Health [REACH] Registry).
Krempf M; Parhofer KG; Steg PG; Bhatt DL; Ohman EM; Röther J; Goto S; Pasquet B; Wilson PW;
Am J Cardiol; 2010 Mar; 105(5):667-71. PubMed ID: 20185014
[TBL] [Abstract][Full Text] [Related]
8. Impact of adherence to antihypertensive agents on clinical outcomes and hospitalization costs.
Dragomir A; Côté R; Roy L; Blais L; Lalonde L; Bérard A; Perreault S
Med Care; 2010 May; 48(5):418-25. PubMed ID: 20393367
[TBL] [Abstract][Full Text] [Related]
9. [Pharmacoeconomic analysis: results of the REACH registry].
Suárez C; Abadía C; Echevarria A
Med Clin (Barc); 2009 Sep; 132 Suppl 2():41-3. PubMed ID: 19631839
[TBL] [Abstract][Full Text] [Related]
10. A comparison of health-care costs involved in treating people with and without Parkinson's disease in Southern Sydney, New South Wales, Australia.
Cordato DJ; Schwartz R; Abbott E; Saunders R; Morfis L
J Clin Neurosci; 2006 Jul; 13(6):655-8. PubMed ID: 16797991
[TBL] [Abstract][Full Text] [Related]
11. Medical care costs among patients with established cardiovascular disease.
Nichols GA; Bell TJ; Pedula KL; O'Keeffe-Rosetti M
Am J Manag Care; 2010 Mar; 16(3):e86-e93. PubMed ID: 20205493
[TBL] [Abstract][Full Text] [Related]
12. Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.
Simoni-Wastila L; Blanchette CM; Qian J; Yang HW; Zhao L; Zuckerman IH; Pak GH; Silver H; Dalal AA
Am J Geriatr Pharmacother; 2009 Oct; 7(5):262-70. PubMed ID: 19948302
[TBL] [Abstract][Full Text] [Related]
13. The REduction of Atherothrombosis for Continued Health (REACH) Registry: an international, prospective, observational investigation in subjects at risk for atherothrombotic events-study design.
Ohman EM; Bhatt DL; Steg PG; Goto S; Hirsch AT; Liau CS; Mas JL; Richard AJ; Röther J; Wilson PW;
Am Heart J; 2006 Apr; 151(4):786.e1-10. PubMed ID: 16569533
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcomes and medical care costs among medicare beneficiaries receiving therapy for peripheral arterial disease.
Jaff MR; Cahill KE; Yu AP; Birnbaum HG; Engelhart LM
Ann Vasc Surg; 2010 Jul; 24(5):577-87. PubMed ID: 20579582
[TBL] [Abstract][Full Text] [Related]
15. Worse blood pressure control in patients with cerebrovascular or peripheral arterial disease compared with coronary artery disease.
Mechtouff L; Touzé E; Steg PG; Ohman EM; Goto S; Hirsch AT; Röther J; Aichner FT; Weimar C; Bhatt DL; Alberts MJ; Mas JL;
J Intern Med; 2010 Jun; 267(6):621-33. PubMed ID: 20210837
[TBL] [Abstract][Full Text] [Related]
16. In Germany diabetic patients with coronary artery disease are treated more intensively than diabetic patients with other manifestations of atherothrombosis--results from the REACH registry.
Parhofer KG; Zeymer U; Stark RG; Binz C; Schwertfeger M; Bhatt DL; Steg PG; Röther J;
Exp Clin Endocrinol Diabetes; 2010 Jan; 118(1):51-6. PubMed ID: 19834877
[TBL] [Abstract][Full Text] [Related]
17. Major complications have an impact on total annual medical cost of diabetes: results of a database analysis.
Morsanutto A; Berto P; Lopatriello S; Gelisio R; Voinovich D; Cippo PP; Mantovani LG
J Diabetes Complications; 2006; 20(3):163-9. PubMed ID: 16632236
[TBL] [Abstract][Full Text] [Related]
18. Impact of donepezil use in routine clinical practice on health care costs in patients with Alzheimer's disease and related dementias enrolled in a large medicare managed care plan: a case-control study.
Lu S; Hill J; Fillit H
Am J Geriatr Pharmacother; 2005 Jun; 3(2):92-102. PubMed ID: 16129386
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of optimizing use of statins in Australia: using outpatient data from the REACH Registry.
Ademi Z; Reid CM; Hollingsworth B; Stoelwinder J; Steg PG; Bhatt DL; Vale M; Liew D;
Clin Ther; 2011 Oct; 33(10):1456-65. PubMed ID: 21982384
[TBL] [Abstract][Full Text] [Related]
20. Direct hospital costs for patients with inflammatory bowel disease in a Canadian tertiary care university hospital.
Bernstein CN; Papineau N; Zajaczkowski J; Rawsthorne P; Okrusko G; Blanchard JF
Am J Gastroenterol; 2000 Mar; 95(3):677-83. PubMed ID: 10710056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
